Clinical and pathologic features of congenital myasthenic syndromes caused by 35 genes—a comprehensive review

K Ohno, B Ohkawara, XM Shen, D Selcen… - International journal of …, 2023 - mdpi.com
Congenital myasthenic syndromes (CMS) are a heterogeneous group of disorders
characterized by impaired neuromuscular signal transmission due to germline pathogenic …

Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment

AG Engel, XM Shen, D Selcen, SM Sine - The Lancet Neurology, 2015 - thelancet.com
The congenital myasthenic syndromes (CMS) are a diverse group of genetic disorders
caused by abnormal signal transmission at the motor endplate, a special synaptic contact …

Emerging structure of the nicotinic acetylcholine receptors

A Karlin - Nature Reviews Neuroscience, 2002 - nature.com
The conversion of acetylcholine binding into ion conduction across the membrane is
becoming more clearly understood in terms of the structure of the receptor and its transitions …

End-plate acetylcholine receptor: structure, mechanism, pharmacology, and disease

SM Sine - Physiological reviews, 2012 - journals.physiology.org
The synapse is a localized neurohumoral contact between a neuron and an effector cell and
may be considered the quantum of fast intercellular communication. Analogously, the …

Novel modulation of neuronal nicotinic acetylcholine receptors by association with the endogenous prototoxin lynx1

I Ibañez-Tallon, JM Miwa, HL Wang, NC Adams… - Neuron, 2002 - cell.com
We previously identified lynx1 as a neuronal membrane molecule related to snake α-
neurotoxins able to modulate nAChRs. Here, we show that lynx1 colocalizes with nAChRs …

Neurosteroids shift partial agonist activation of GABAA receptor channels from low-to high-efficacy gating patterns

MT Bianchi, RL Macdonald - Journal of Neuroscience, 2003 - Soc Neuroscience
Although GABA activates synaptic (αβγ) GABAA receptors with high efficacy, partial agonist
activation of αβγ isoforms and GABA activation of the primary extrasynaptic (αβδ) GABAA …

Sleuthing molecular targets for neurological diseases at the neuromuscular junction

AG Engel, K Ohno, SM Sine - Nature Reviews Neuroscience, 2003 - nature.com
The analysis of congenital myasthenic syndromes (CMSs) has disclosed a diverse array of
molecular targets at the motor endplate and has delineated their contribution to synaptic …

Current understanding of congenital myasthenic syndromes

AG Engel, SM Sine - Current opinion in pharmacology, 2005 - Elsevier
Investigation of congenital myasthenic syndromes (CMSs) disclosed a diverse array of
molecular targets at the motor endplate. Clinical, electrophysiologic and morphologic …

Genetic basis and phenotypic features of congenital myasthenic syndromes

AG Engel - Handbook of clinical neurology, 2018 - Elsevier
The congenital myasthenic syndromes (CMS) are heterogeneous disorders in which the
safety margin of neuromuscular transmission is compromised by one or more specific …

[HTML][HTML] Nicotinic acetylcholine receptors in human genetic disease

CP Schaaf - Genetics in Medicine, 2014 - Elsevier
Nicotinic acetylcholine receptors represent a family of ligand-gated ion channels that are
widely expressed in the central and peripheral nervous systems. To date, 16 genes …